Janssen Search
Search results
Tammy Guld, M.S.
Tammy Guld, M.S. GLOBAL LEAD, JCI Tammy is the Global Lead of Janssen Clinical Innovation, with more than 20 years of experience in strategic and operational delivery across clinical development, regulatory affairs, and healthcare innovation. Based in New ...
About Us
About Us We are a global research platform exploring new approaches to disease prevention. We aim to discover and design science-based solutions to keep people healthy and vital for life. Our research is focused on the prevention of illnesses that come ...
Dr. Paul Stoffels Reflects On The Progress We Have Made Against HIV
Dr. Paul Stoffels Reflects on the Progress We Have Made Against HIV Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson, has spent much of his career fighting AIDS. To mark World AIDS Day (Dec. 1, 2016) our colleagues at Johnson & ...
How Patients’ Genetic Information is Driving Improvements in Lung Cancer Therapeutics
How Patients’ Genetic Information is Driving Improvements in Lung Cancer Therapeutics This week, I’m looking forward to joining colleagues at the International Association for the Study of Lung Cancer’s (IASLC) 2020 World Congress Lung Cancer (WCLC) to ...
Sustainable Practices- Green Chemistry
Green Chemistry: Innovation in Chemical Development The emerging attention on the responsible use of pharmaceutical chemicals is the focus of our new Janssen.com series on green chemistry. Below, you can learn about green chemistry and Janssen’s longtime ...
Kate Owen
KATE OWEN HEAD JANSSEN GLOBAL DEVELOPMENT As Head of Global Development at the Janssen Pharmaceutical Companies of Johnson & Johnson, Kate oversees a team of 10,000 experts that are the backbone of drug development, accelerating the delivery of ...
The Mind Matters: This Janssen Researcher is On a Mission to Change How We Treat Mental Illness
The Mind Matters: This Janssen Researcher is On a Mission to Change How We Treat Mental Illness Janssen’s Husseini Manji, M.D., is working toward a world in which diseases like depression and schizophrenia are diagnosed quickly and handled without stigma. ...
Our Partnerships
Our Partnerships Partnerships are central to all that we do. Beyond our research and development (R&D) partnerships, we recognize the importance of building multi-sector alliances to address critical health needs. We are committed to working across ...
Progress, Patients & Passion: Reflections on World Cancer Day 2019
Progress, Patients & Passion: Reflections on World Cancer Day 2019 A little over a decade ago, February 4 was declared World Cancer Day in an effort to raise awareness and education of cancer, and encourage a global unified fight against the disease ...
The Potential of Biomarkers in Oncology Drug Development
Article Type: Oncology Realizing the Potential of Biomarkers in Oncology Drug Development It’s a real paradox: As of March 2014, there were more than 31,850 biomarkers listed in the GOBIOM database (GVK BIO Online Biomarker Database), but only 32 valid ...